Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia (REPAIR)


March 1, 2013

Clinical trial

Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study.

Tufail A, Patel PJ, Sivaprasad S, Amoaku W, Browning AC, Cole M, Gale R, George S, Lotery AJ, Majid M, McKibbin M, Menon G, Yang Y, Andrews C, Brittain C, Osborne A.

Eye (Lond). 2013 Jun;27(6):709-15.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive